Fujifilm Pharmaceuticals U.s.a., Inc.
Clinical trials sponsored by Fujifilm Pharmaceuticals U.s.a., Inc., explained in plain language.
-
New hope for tough cancers: experimental combo targets advanced lung & bladder tumors
Disease control OngoingThis study is testing a new drug called FF-10832, given alone or combined with the immunotherapy pembrolizumab, for people with advanced lung or bladder cancer that has worsened after previous treatment. The main goals are to find a safe dose and see if the treatment can help con…
Phase: PHASE2 • Sponsor: Fujifilm Pharmaceuticals U.S.A., Inc. • Aim: Disease control
Last updated Apr 04, 2026 00:34 UTC
-
New cancer drug enters first human safety testing
Disease control OngoingThis early-stage study aims to determine the safety and appropriate dosage of a new experimental cancer drug called FF-10850. The trial will enroll approximately 96 adults with advanced solid tumors that have not responded to standard treatments, including ovarian cancer and Merk…
Phase: PHASE1 • Sponsor: Fujifilm Pharmaceuticals U.S.A., Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC